Senetek and ICN partner for anaphylactic injector:
This article was originally published in Clinica
Senetek of Napa, California and ICN Pharmaceuticals of New York, have signed an agreement that gives ICN worldwide rights to AdrenaJect, Senetek's epinephrine filled ReliaJect autoinjector. The device is used by those suffering anaphylactic shock, caused by such events as adverse allergy reactions from insect bites or foods. Senetek will also make available the autoinjector for other therapeutics such as pains management and infertility.
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.